Glucose metabolic upregulation via phosphorylation of S6 ribosomal protein affects tumor progression in distal cholangiocarcinoma.
Atsuro FujinagaTeijiro HirashitaYuka HirashitaKumiko SakaiMasahiro KawamuraTakashi MasudaYuichi EndoMasayuki OhtaKazunari MurakamiMasafumi InomataPublished in: BMC gastroenterology (2023)
Upregulation of glucose metabolism via phosphorylation of S6 ribosomal protein appeared to play a role in tumor progression in dCCA. mTORC1 may be a therapeutic target for dCCA.